Zepbound vials vs KwikPen vs pen: which forms are there, and which does Medicare cover?
Four forms of the same medicine. How each one is used and stored, what Lilly lists as the self-pay price, and why only the KwikPen counts for the Medicare GLP‑1 Bridge.
Written for the United States. Other country versions are coming.
Zepbound comes as a single-dose pen, a single-dose vial, a multi-dose vial and a 4-dose KwikPen, all the same medicine and doses. Lilly lists vials and KwikPens at $299 to $699 a month self-pay by dose. Medicare’s GLP‑1 Bridge covers only the KwikPen.
Key takeaways
- Zepbound comes in four forms (single-dose pen, single-dose vial, multi-dose vial and 4-dose KwikPen), all tirzepatide in weekly doses of 2.5 mg to 15 mg.1
- Lilly lists self-pay prices for single-dose vials and KwikPens of $299 at 2.5 mg, $399 at 5 mg and $449 at higher doses with refills within 45 days.5
- Medicare’s GLP‑1 Bridge covers only the Zepbound KwikPen for weight; CMS says the single-dose pen and vials are not covered.7
- Single-dose pens and vials can spend up to 21 days in total out of the fridge at up to 86°F; KwikPens and multi-dose vials up to 30 days.1
- In the Zepbound weight trials, 25 to 29 in 100 had nausea against 8 in 100 on a dummy injection, whatever the form.1
On this page
What forms does Zepbound come in?
Four: a single-dose pen, a single-dose vial, a multi-dose vial and a 4-dose KwikPen. All hold the same medicine, tirzepatide, in the same weekly doses of 2.5 mg to 15 mg.1
- GLP‑1 medicines are prescription-only in the US. A licensed prescriber decides whether one fits you, and which form.
- Label facts here come from the current US Zepbound prescribing information and each form’s Instructions for Use, the step-by-step leaflet in the box.1,2,3,4
- This post compares forms and published prices. It does not recommend one, and no form changes what the medicine does.
- Every risk of these medicines is in our side-effects guide.
Tirzepatide is the medicine; Zepbound is Eli Lilly’s brand for weight management and sleep apnea. The label says each patient should be trained for the form they get, and retrained if the form changes.1
- Single-dose pen: a prefilled pen used once, then thrown away. A box holds 4.1,2
- Single-dose vial: a small glass bottle with one dose. You draw it up with a syringe and needle bought separately.1,3
- Multi-dose vial: one bottle with 4 weekly doses of 0.6 mL, drawn up with a syringe.1
- KwikPen: one pen with 4 fixed weekly doses. You attach a new pen needle each week; needles are not included.1,4
How does using each one differ?
The single-dose pen has the fewest steps. Vials need a syringe and needle each week. The KwikPen needs a new pen needle and a priming step before each dose.2,3,4
| Form | What you do each week | Worth knowing |
|---|---|---|
| Single-dose pen | Pull off the base cap, place it on the skin, unlock, then press and hold the button for up to 10 seconds.2 | Nothing to measure. One pen per dose.1,2 |
| Single-dose vial | Draw 0.5 mL into a new syringe and inject.1,3 | Use a new syringe and needle every time. Throw the vial away after use, even if some is left.3 |
| Multi-dose vial | Draw 0.6 mL into a new syringe and inject.1 | Four doses from one bottle; label storage limits apply once opened.1 |
| KwikPen | Attach a new needle, prime until a drop appears, turn the dose knob all the way, inject.4 | The pen stops after 4 doses. Don’t inject the leftover or move it into a syringe.4 |
- Never share a KwikPen, even with a new needle; the label added this warning in January 2026 because of infection risk.1,4
- Vision problems: the label says the KwikPen is not recommended for self-injection by people who are visually impaired, and the leaflet says not to use it without help from a trained person.1,4
- Missed dose (all forms): take it within 4 days (96 hours). After that, skip it and take the next one on your usual day.1
How should each form be stored?
Single-dose pens and vials live in the fridge and can spend up to 21 days in total at room temperature. Multi-dose vials and KwikPens can sit at room temperature for up to 30 days once in use.1
| Form | In the fridge | Out of the fridge (up to 86°F / 30°C) |
|---|---|---|
| Single-dose pen or vial | 36–46°F (2–8°C)1 | Up to 21 days in total, then throw it away.1 |
| Multi-dose vial or KwikPen, unopened | Until the expiration date1 | Throw away after 30 days.1 |
| Multi-dose vial or KwikPen, in use | Fridge or room temperature1 | Throw away after 30 days at room temperature, 30 days after first use, or after 4 doses, whichever comes first.1 |
For every form: don’t freeze it, don’t use it if it has been frozen, and keep it in the carton away from heat and light.1
What does each form cost without insurance?
Lilly lists the same self-pay prices for single-dose vials and KwikPens: $299 a month at 2.5 mg, $399 at 5 mg, and $449 at higher doses if you refill within 45 days. Checked October 12, 2026.5
Without a refill inside 45 days, Lilly lists $499 for 7.5 mg and $699 for 10 to 15 mg.5 A “month” here is one KwikPen or four single-dose vials, so four weekly doses.1,5
- Single-dose vials: Lilly says these are available only through its own pharmacy service.5
- KwikPen: Lilly says self-pay pricing can also be used at retail pharmacies.5
- Single-dose pen: Lilly’s page lists it under insurance options and gives no self-pay price for it.5
- Multi-dose vial: it is on the label, but we found no published self-pay price for it.1,5
TrumpRx, a government price-listing site, shows Zepbound’s list price as $1,087 a month.6
Works out a monthly and yearly cost from the prices you enter. No sign-up.
Which form does Medicare cover?
For weight, Medicare’s temporary GLP‑1 Bridge covers only the Zepbound KwikPen. CMS says “the single-dose Zepbound pen and Zepbound vials are NOT covered.”7
The Bridge runs from July 1, 2026, to December 31, 2027, with a $50 monthly copay, for people who meet its rules. Only 28-day or 30-day fills are covered.7
If you use Zepbound for sleep apnea, the request goes to your own Part D drug plan instead, which can cover GLP‑1s for approved uses other than weight.8 People with moderate-to-severe sleep apnea can’t use the Bridge.7 We found no Medicare rule limiting the sleep-apnea route to one form.
What should you ask before picking a form?
Ask what your plan or program covers, whether you are comfortable drawing up a syringe, and where you will store it. Your prescriber and pharmacist can show you each device.
- Coverage: which forms does my plan cover, or does Medicare’s Bridge apply to me (KwikPen only)?7
- Handling: can I measure 0.5 or 0.6 mL with a syringe each week, or would a pen suit me better?1
- Eyesight and hands: can I read the KwikPen dose window and turn the knob?4
- Storage: can I keep it cold, or do I need a form that is fine at room temperature for longer?1
- Supplies: who provides syringes, pen needles and a sharps container?3,4
- Stomach effects are the most common. In the Zepbound weight trials, 25 to 29 in 100 felt sick (nausea) against 8 in 100 on a dummy injection.1
- Injection-site reactions affected 6 to 8 in 100 on Zepbound against 2 in 100 on the dummy.1
- Pancreatitis and gallbladder problems are label warnings. Stop and seek advice if pancreatitis is suspected.1
- The birth-control pill may work less well for 4 weeks after starting and after each dose increase.1
- Thyroid tumors were seen in rats; Zepbound carries a boxed warning.1
Questions people ask
Is the Zepbound vial the same as the pen?
Yes, it is the same medicine and dose. The single-dose vial is drawn up with a syringe; the pen injects it for you.1,2,3
How many doses are in a Zepbound KwikPen?
Four fixed weekly doses. After the fourth, the pen won’t dial a full dose; throw it away, including any leftover.4
Does Medicare cover Zepbound vials?
Not under the Medicare GLP‑1 Bridge, which covers only the KwikPen for weight. Sleep-apnea use goes through your Part D plan.7
How much are Zepbound vials without insurance?
Lilly lists $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg with refills within 45 days, checked October 12, 2026.5
How long can Zepbound stay out of the fridge?
Single-dose pens and vials: up to 21 days in total at up to 86°F. KwikPens and multi-dose vials: up to 30 days.1
How we researched this
On October 12, 2026, we read the current US Zepbound label, the three Instructions for Use leaflets (pen, vial and KwikPen), Lilly’s published self-pay prices, TrumpRx, CMS’s Bridge prescriber sheet, a KFF brief and the FDA’s page on unapproved GLP‑1 drugs.
Prices are Lilly’s own self-pay prices and the list price on TrumpRx; we left out savings-card prices. We name no pharmacy or telehealth service. Side-effect figures come from the Zepbound weight trials, which Eli Lilly paid for.
Before you move on
- All four forms hold the same medicine in the same doses.
- Vials need a new syringe and needle each week; the KwikPen needs a new pen needle and priming.
- Lilly lists the same self-pay prices for vials and KwikPens.
- Medicare’s Bridge covers the KwikPen only.
More from the US blog
The monthly US update
An independent guide to GLP‑1 medicines. We don't sell medicines, take drug-company money or earn clinic commissions. Once a month: FDA approvals and safety notices, label changes, Medicare and Medicaid coverage changes, and published price changes. How we write
Sources
- Eli Lilly. Zepbound (tirzepatide) injection: US prescribing information, revised 08/2026. pi.lilly.com
- Eli Lilly. Zepbound single-dose pen Instructions for Use (US), revised April 2026. pi.lilly.com
- Eli Lilly. Zepbound single-dose vial Instructions for Use (US), revised April 2026. pi.lilly.com
- Eli Lilly. Zepbound KwikPen Instructions for Use (US), revised January 2026. pi.lilly.com
- Eli Lilly. Zepbound coverage and savings (self-pay prices for single-dose vials and KwikPen), CMAT-22250 08/2026, opened October 12, 2026. zepbound.lilly.com
- TrumpRx.gov (US government price-listing site). GLP‑1 listings with "original price", opened October 12, 2026. trumprx.gov
- Centers for Medicare & Medicaid Services (CMS). Medicare GLP‑1 Bridge: information for prescribers. CMS Product No. 12235, June 2026. cms.gov
- KFF. What to know about the BALANCE Model for GLP‑1s in Medicare and Medicaid and the Medicare GLP‑1 Bridge. Updated May 11, 2026. kff.org
- Poison Control (National Capital Poison Center). Opened October 12, 2026. poison.org
- FDA. FDA’s concerns with unapproved GLP‑1 drugs used for weight loss. Content current as of October 1, 2026. fda.gov
Last checked Oct 12, 2026 · Next review due Apr 12, 2027 · Report an error
How this post was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical, legal or tax advice. Talk to a qualified doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. How we write